Market Research Life Sciences Market Research Pharmaceuticals Market Research Over-the-Counter Drugs Market Research

Global Over-the-Counter (OTC) Drug Markets

Best Price Guarantee Length Publisher Published Date SKU
from $3,995 171 Pages Kalorama Information January, 2018 KLI15581138
Best Price Guarantee
Price from $3,995
Length 171 Pages
Publisher Kalorama Information
Published Date January, 2018
SKU KLI15581138

Global Over-the-Counter (OTC) Drug Markets

Global Over-the-Counter (OTC) Drug Markets discusses the world and regional OTC markets, including information on the following: world OTC drug market revenues: 2017 to 2023; top twenty OTC drug markets, country market share (%), 2017 (United States, Japan, China, Germany, France, India, Brazil, Russia, United Kingdom, Australia, Mexico, Canada, Italy, Spain, Poland, Turkey, Argentina, Venezuela, South Africa, Saudi Arabia, rest of world); and world OTC drug market revenues, markets by product segment, 2017 to 2023 (central nervous system, dermatological, gastrointestinal, respiratory, other, total). The coverage of regional OTC markets in the report goes to the country level in North America, Asia Pacific, Europe, Latin America, and Middle East and Africa.

Kalorama Information divides and discusses OTC product markets in five general segments: OTC central nervous system agents (analgesics, anti-inflammatories, and other central nervous system agents), OTC dermatological agents (acne treatments, antifungals/antiinfectives, hair growth remedies, others), OTC gastrointestinal system agents (laxatives, antacids, antidiarrheals, H2 antagonists, proton pump inhibitors), OTC respiratory system agents (antihistamines, decongestants, cough preparations, other respiratory agents), and OTC agents – various therapeutic classifications (smoking cessation market, contraceptive drugs, weight management drugs [OTC drugs, not dietary supplements], overactive bladder treatments).

Global OTC Drug Markets notes the leading suppliers’ shares of the OTC drug market by revenues for 2017 and also includes in-depth profiles of market competitors such as Bayer, Johnson & Johnson, Pfizer, Procter & Gamble, and Sanofi.


  • Executive Summary
    • Background
    • Scope and Methodology
    • Size and Growth of the Global OTC Market
      • Table Figure 1-1: Global Over-the-Counter Drug Market Analysis: 2017 to 2023 (millions USD)
      • Global Markets
        • Table Figure 1-2: Top Twenty OTC Drug Markets, Country Market Share (%), 2017
      • Leading Competitors
  • Introduction
    • Background
    • Distribution and Safety Issues in the United States
    • Consumer Advertising and Promotion
    • Global Health
      • Global Life Expectancy
        • Table Average Life Expectancy in Years by Country, 2017 and Projected 2025
        • Table Figure 2-1: Average Life Expectancy in Years by Country, 2017 and Projected 2025
      • Global Trends in Birth Rates
        • Table Crude Birth Rate per 1,000 Persons by Country, 2017 and Projected 2025
        • Table Figure 2-2: Crude Birth Rate per 1,000 Persons by Country, 2017 and Projected 2025
      • Tobacco Use
        • Table Figure 2-3: Percent of Tobacco Users as a Percentage of Population by Country, 1990 vs. 2010 (%)
      • Obesity
        • Table Figure 2-4: Obesity Prevalence as a Percentage of Population by Country, 2006 vs. 2016 (%)
      • Declining Growth of the Global Population
        • Table Global Population 1980 to 2050 (millions)
        • Table Figure 2-5: The Global Population, 1980-2050
        • Table Figure 2-6: Global Population Trends, Total Population vs. Age 65+ Population, 2000-2050
    • Prescription vs. Over-the-Counter Industry
      • Table Figure 2-7: Total Pharmaceutical Markets: Prescription vs. Non-Prescription by Country, 2017 (% of total
    • Over-the-Counter Drug Product Segments
      • Table Global OTC Drug Market Analysis, Markets by Product Segment, 2017 to 2023 (in millions of dollars at the manufacturers' level)
      • Table Figure 2-8: Global OTC Drug Market Analysis, Markets by Product Segment, 2017 and 2023
    • Rx-to-OTC Switch Industry
      • Table Leading FDA approved Rx-to-OTC switches, 1994-2017
      • Table Figure 2-9: Number of New Rx-to-OTC Switches in the United States, per year 1976-2017
    • Economic Trends
      • Table Figure 2-10: Total Healthcare Expenditures as a Percent of GDP by Country 1990, 2000, 2010 and 2020 Estimated (%)
      • Purchasing Power Trends
        • Table Figure 2-11: Gross National Income by Country 1990-2010 and Estimated 2020
    • Health Insurance Issues and Trends: United States
      • Table Figure 2-12: Number of Insured vs. Uninsured in the United States 2005-2016
      • Table Figure 2-13: Number of Insured Children vs. Uninsured Children in the United States 2005-2016
      • Table Figure 2-14: Number of Insured Children vs. Uninsured Children in the United States 2005-2016
    • Consumer Issues and Trends
      • Access to Professional Medical Services and the Link to Self-Medication
        • Table Figure 2-15: Practicing Physicians per 1,000 Population by Country, 2017
    • Regulatory Solutions to OTC Drug Access
      • Revisions to Pharmaceutical Affairs Law (PAL) in Japan
        • Table Figure 2-16: Typical Pharmacist-Consumer OTC Drug Counseling Session
      • Changes to Australia's OTC Drug Access - Up-scheduling Combination Medicines Containing Codeine
        • Table Figure 2-17: National Classification System of Scheduling Medicines
  • Over The Counter Central Nervous System Agents
    • Market Summary
      • Table Figure 3-1: Global OTC Central Nervous System Agent Market, 2017-2023
    • Market By Drug Segment
      • Table Figure 3-2: Global OTC Central Nervous System Agent Market, Distribution of Sales by Drug Segment 2017 (%)
    • Markets by Region
      • Asia Pacific
        • Table Figure 3-3: Asia Pacific OTC Central Nervous System Agent Market, 2017-2023 ($ millions)
      • Europe
        • Table Figure 3-4: Europe OTC Central Nervous System Agent Market, 2017-2023 ($ millions)
      • Latin America
        • Table Figure 3-5: Latin America OTC Central Nervous System Agent Market, 2017-2023 ($ millions)
      • Middle East & Africa
        • Table Figure 3-6: Middle East & Africa OTC Central Nervous System Agent Market, 2017-2023 ($ millions)
      • North America
        • Table Figure 3-7: North America OTC Central Nervous System Agent Market, 2017-2023 ($ millions)
  • Over-the-Counter Dermatological Agents
    • Market Summary
      • Table Figure 4-1: Global OTC Dermatological Agent Market, 2017-2023
    • Market by Drug Segment
      • Table Figure 4-2: Global OTC Dermatological Agent Market, Distribution of Sales by Drug Segment 2017 (%)
    • Markets by Region
      • Asia Pacific
        • Table Figure 4-3: Asia Pacific OTC Dermatological Agent Market, 2017-2023 ($ millions)
      • Europe
        • Table Figure 4-4: Europe OTC Dermatological Agent Market, 2017-2023 ($ millions)
      • Latin America
        • Table Figure 4-5: Latin America OTC Dermatological Agent Market, 2017-2023 ($ millions)
      • Middle East & Africa
        • Table Figure 4-6: Middle East & Africa OTC Dermatological Agent Market, 2017-2023 ($ millions)
      • North America
        • Table Figure 4-7: North America OTC Dermatological Agent Market, 2017-2023 ($ millions)
  • Over-the-Counter Gastrointestinal System Agents
    • Market Summary
      • Table Figure 5-1: Global OTC Gastrointestinal Agent Market, 2017-2023
    • Market by Drug Segment
      • Table Figure 5-2: Global Gastrointestinal OTC Market, Distribution of Sales by Drug Segment 2017 (%)
    • Markets by Region
      • Asia Pacific
        • Table Figure 5-3: Asia Pacific OTC Gastrointestinal Agent Market, 2017-2023 ($ millions)
      • Europe
        • Table Figure 5-4: Europe OTC Gastrointestinal Agent Market, 2017-2023 ($ millions)
      • Latin America
        • Table Figure 5-5: Latin America OTC Gastrointestinal Agent Market, 2017-2023 ($ millions)
      • Middle East & Africa
        • Table Figure 5-6: Middle East & Africa OTC Gastrointestinal Agent Market, 2017-2023 ($ millions)
      • North America
        • Table Figure 5-7: North America OTC Gastrointestinal Agent Market, 2017-2023 ($ millions)
  • Over-the-Counter Respiratory System Agents
    • Market Summary
      • Table Figure 6-1: Global OTC Respiratory Agent Market, 2017-2023
    • Market by Drug Segment
      • Table Figure 6-2: Global OTC Respiratory Agent Market, Distribution of Sales by Drug Segment 2017 (%)
      • Table Global OTC Respiratory Agent Market, Sales by Indication, 2017-2023 ($ in millions)
      • Table Figure 6-3: Global OTC Respiratory Agent Market, Distribution of Sales by Indication 2017 (%)
    • Markets by Region
      • Asia Pacific
        • Table Figure 6-4: Asia Pacific OTC Respiratory Agent Market, 2017-2023 ($ millions)
      • Europe
        • Table Figure 6-5: Europe OTC Respiratory Agent Market, 2017-2023 ($ millions)
      • Latin America
        • Table Figure 6-6: Latin America OTC Respiratory Agent Market, 2017-2023 ($ millions)
      • Middle East & Africa
        • Table Figure 6-7: Middle East & Africa OTC Respiratory Agent Market, 2017-2023 ($ millions)
      • North America
        • Table Figure 6-8: North America OTC Respiratory Agent Market, 2017-2023 ($ millions)
  • Over-the-Counter Agents-Various Therapeutic Classifications
    • Market Summary
      • Table Figure 7-1: Global OTC Other Therapies Market, 2017-2023
    • Markets by Region
      • Asia Pacific
        • Table Figure 7-2: Asia Pacific OTC Other Therapies Market, 2017-2023 ($ millions)
      • Europe
        • Table Figure 7-3: Europe OTC Other Therapies Market, 2017-2023 ($ millions)
      • Latin America
        • Table Figure 7-4: Latin America OTC Other Therapies Market, 2017-2023 ($ millions)
      • Middle East & Africa
        • Table Figure 7-5: Middle East & Africa OTC Other Therapies Market, 2017-2023 ($ millions)
      • North America
        • Table Figure 7-6: North America OTC Other Therapies Market, 2017-2023 ($ millions)
  • OTC Drug Markets in Asia Pacific
    • Regional Overview
      • Table Asia Pacific Select Countries, Demographic Profile, 2017 and 2030
      • Table Figure 8-1: Population Growth vs. Aging Population Growth by Country, 2017-2030
    • OTC Drug Sales and Growth in Asia Pacific Markets
      • Table Figure 8-2: OTC Drug Market in Asia Pacific Region, 2017-2023 (in millions of dollars at the manufacturers' level)
      • Sales for OTC Drug Markets by Country
        • Table Figure 8-3: Asia Pacific OTC Drug Market Value by Country, 2017 and 2023
        • Table Figure 8-4: Asia Pacific OTC Drug Markets by Country, 2017 (%)
        • Table Figure 8-5: OTC Drug Markets in Japan by Therapeutic Class, 2017 (%)
        • Table Figure 8-6: OTC Drug Markets in China by Therapeutic Class, 2017 (%)
        • Table Figure 8-7: OTC Drug Markets in India by Therapeutic Class, 2017 (%)
        • Table Figure 8-8: OTC Drug Markets in Australia by Therapeutic Class, 2017 (%)
    • Asia Pacific OTC Markets by Therapeutic Class
      • Table Asia-Pacific OTC Drug Market Analysis by Therapeutic Class, 2017 and 2023 (in millions of dollars at the manufacturers' level)
      • Table Figure 8-9: Asia-Pacific OTC Drug Market by Therapeutic Class, 2017 and 2023
  • OTC Drug Markets in Europe
    • Regional Overview
      • Table Europe Select Countries, Demographic Profile, 2017 and 2030
      • Table Figure 9-1: Population Growth vs. Aging Population Growth by Country, 2017-2030
    • OTC Drug Sales and Growth in Europe Markets
      • Table Figure 9-2: OTC Drug Market in Europe Region, 2017-2023 (in millions of dollars at the manufacturers' level)
    • Sales for OTC Drug Markets by European Country
      • Table Figure 9-3: Europe OTC Drug Market Value by Country, 2017 and 2023
      • Table Figure 9-4: Europe OTC Drug Markets by Country, 2017 (%)
      • Germany
        • Table Figure 9-5: OTC Drug Markets in Germany by Therapeutic Class, 2017 (%)
      • France
        • Table Figure 9-6: OTC Drug Markets in France by Therapeutic Class, 2017 (%)
      • Russia
        • Table Figure 9-7: OTC Drug Markets In Russia by Therapeutic Class, 2017 (%)
      • United Kingdom
        • Table Figure 9-8: OTC Drug Markets in The United Kingdom by Therapeutic Class, 2017 (%)
      • Italy
        • Table Figure 9-9: OTC Drug Markets in Italy by Therapeutic Class, 2017 (%)
      • Spain
        • Table Figure 9-10: OTC Drug Markets in Spain by Therapeutic Class, 2017 (%)
      • Poland
        • Table Figure 9-11: OTC Drug Markets in Poland by Therapeutic Class, 2017 (%)
      • Turkey
        • Table Figure 9-12: OTC Drug Markets in Turkey by Therapeutic Class, 2017 (%)
    • Europe OTC Markets by Therapeutic Class
      • Table Europe OTC Drug Market Analysis by Therapeutic Class, 2017 and 2023 (in millions of dollars at the manufacturers' level)
      • Table Figure 9-13: Europe OTC Drug Market by Therapeutic Class, 2017 and 2023
  • OTC Drug Markets in Latin America
    • Regional Overview
      • Table Latin America Select Countries, Demographic Profile, 2017 and 2030
      • Table Figure 10-1: Population Growth vs. Aging Population Growth by Country, 2017-2030
    • OTC Drug Sales and Growth in Latin America Markets
      • Table OTC Drug Market in Latin America Region, 2017-2023 (in millions of dollars at the manufacturers' level)
    • Sales for OTC Drug Markets by Country
      • Table Figure 10-2: Latin America OTC Drug Market Value by Country, 2017 and 2023
      • Table Figure 10-3: Latin America OTC Drug Markets by Country, 2017 (%)
      • Brazil
        • Table Figure 10-4: OTC Drug Markets in Brazil by Therapeutic Class, 2017 (%)
      • Mexico
        • Table Figure 10-5: OTC Drug Markets in Mexico by Therapeutic Class, 2017 (%)
      • Argentina
        • Table Figure 10-6: OTC Drug Markets in Argentina by Therapeutic Class, 2017 (%)
      • Venezuela
        • Table Figure 10-7: OTC Drug Markets in Venezuela by Therapeutic Class, 2017 (%)
    • Latin America OTC Markets by Therapeutic Class
      • Table Latin America OTC Drug Market Analysis by Therapeutic Class, 2017 and 2023 (in millions of dollars at the manufacturers' level)
      • Table Figure 10-8: Latin America OTC Drug Market by Therapeutic Class, 2017 and 2023
  • OTC Drug Markets in Middle East & Africa
    • Regional Overview
      • Table Middle East & Africa Select Countries, Demographic Profile, 2017 and 2030
      • Table Figure 11-1: Population Growth vs. Aging Population Growth by Country, 2017-2030
    • OTC Drug Sales and Growth in Middle East & Africa Markets
      • Table Figure 11-2: OTC Drug Market in Middle East & Africa Region, 2017-2023 (in millions of dollars at the manufacturers' level)
    • Sales for OTC Drug Markets by Country
      • Table Figure 11-3: Middle East & Africa OTC Drug Market Value by Country, 2017 and 2023
      • Table Figure 11-4: OTC Drug Markets by Country, 2017 (%)
      • South Africa
        • Table Figure 11-5: OTC Drug Markets in South Africa by Therapeutic Class, 2017 (%)
      • Saudi Arabia
        • Table Figure 11-6: OTC Drug Markets in Saudi Arabia by Therapeutic Class, 2017 (%)
    • Middle East & Africa OTC Markets by Therapeutic Class
      • Table Middle East & Africa OTC Drug Market Analysis by Therapeutic Class, 2017 and 2023 (in millions of dollars at the manufacturers' level)
      • Table Figure 11-7: Middle East & Africa OTC Drug Market by Therapeutic Class, 2017 and 2023
  • OTC Drug Markets in North America
    • Regional Overview
      • Table North America Select Countries, Demographic Profile, 2017 and 2030
      • Table Figure 12-1: Population Growth vs. Aging Population Growth by Country, 2017-2030
    • OTC Drug Sales and Growth in North America Markets
      • Table Figure 12-2: OTC Drug Markets in North America Region, 2017-2023 (in millions of dollars at the manufacturers' level)
      • Sales for OTC Drug Markets by Country
        • Table Figure 12-3: North America OTC Drug Market Value by Country, 2017 and 2023
        • Table Figure 12-4: North America OTC Drug Markets by Country, 2017 (%)
      • United States
        • Table Figure 12-5: OTC Drug Markets in the United States by Therapeutic Class, 2017 (%)
      • Canada
        • Table Figure 12-6: OTC Drug Markets in Canada by Therapeutic Class, 2017 (%)
    • North America OTC Markets by Therapeutic Class
      • Table North America OTC Drug Market Analysis by Therapeutic Class, 2017 and 2023 (in millions of dollars at the manufacturers' level)
      • Table Figure 12-7: North America OTC Drug Market by Therapeutic Class, 2017 and 2023
  • Leading OTC Drug Manufacturers
    • Overview
    • Competitor Analysis
      • GlaxoSmithKline Grabs Top Market Position
      • Bayer Holds Second in a Highly Competitive Market
      • Sanofi Climbs to Third in Market with Recent Acquisition
      • Johnson & Johnson Maintains a Top Market Position in OTC Drugs despite Growing Consolidation and Competition
      • Reckitt Benckiser Maintains Consistent Sales
      • Perrigo Is the Leading Off-Brand OTC Drug Company
      • Pfizer Is Steadfast
      • Taisho Pharmaceutical: Japan's Leading OTC Drug Supplier
      • Procter & Gamble Shows Slow, Steady Growth
        • Table Leading Suppliers Shares of the OTC Drug Market by Revenues-2017
        • Table Figure 13-1: Leading Suppliers Shares of the OTC Drug Market, 2017
    • A Decade of Agreements, Mergers and Acquisitions Shaping the OTC Drug Market
      • Sanofi and Boehringer Ingelheim
      • GlaxoSmithKline and Novartis AG
      • Bayer AG and Merck & Co.
      • Prestige Brands and Insight Pharmaceuticals
      • Perrigo Company Acquisitions
      • Procter & Gamble and Teva Pharmaceutical Industries
      • Sanofi and Chattem Consumer
      • Wyeth and Pfizer
      • Reckitt Benckiser and Adams Respiratory Therapeutics
    • Leading Corporate Profiles
      • Bayer AG
        • Table Bayer Corporate Summary
        • Table Bayer Recent Revenue History, 2015-2017 (US$ Millions, financial year ending December)
      • GlaxoSmithKline plc
        • Table GlaxoSmithKline Corporate Summary
        • Table GlaxoSmithKline Recent Revenue History, 2015-2017 (US$ Millions, financial year ending December)
      • Johnson & Johnson
        • Table Johnson & Johnson Corporate Summary
        • Table Johnson & Johnson Recent Revenue History, 2015-2017 (US$ Millions, financial year ending December)
      • Mylan N.V.
        • Table Mylan Corporate Summary
        • Table Mylan Recent Revenue History, 2015-2017 (US$ Millions, financial year ending December)
      • Perrigo Company plc
        • Table Perrigo Company Corporate Summary
        • Table Perrigo Recent Revenue History, 2015-2017 (US$ Millions, financial year ending December)
      • Pfizer, Inc.
        • Table Pfizer Corporate Summary
        • Table Pfizer Recent Revenue History, 2015-2017 (US$ Millions, financial year ending December)
      • Procter & Gamble Company
        • Table Procter & Gamble Company Corporate Summary
        • Table Procter & Gamble Recent Revenue History, 2015-2017 (US$ Millions, financial year ending June)
      • Reckitt Benckiser Group Plc
        • Table Reckitt Benckiser Group Corporate Summary
        • Table Reckitt Benckiser Recent Revenue History, 2015-2017 (US$ Millions, financial year ending December)
      • Sanofi
        • Table Sanofi Corporate Summary
        • Table Sanofi Recent Revenue History, 2015-2017 (US$ Millions, financial year ending December)
      • Taisho Pharmaceutical Holding Co., Ltd.
        • Table Taisho Pharmaceutical Holding Corporate Summary
        • Table Taisho Pharmaceutical Recent Revenue History, FY End 2016-2017 (US$ Millions, financial year ending March)

$3,995
$5,995
$7,990

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings